Toevoegen aan een lijst
|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 10.402,00 GBX | +0,10% |
|
-3,79% | -0,57% |
| 06:52 | Zweedse aandelen in Noord-Amerika - Autoliv stijgt met 1,3 procent | FW |
| 20/06 | FTSE 100 boekt eerste wekelijkse daling in zes weken; Spanningen in het Midden-Oosten centraal | RE |
Voorlopige winst- en verliesrekening: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 26.617 | 37.417 | 44.351 | 45.811 | 54.073 | 57.830 | 61.182 | 64.582 |
| Variatie | - | 40,58% | 18,53% | 3,29% | 18,03% | 6,95% | 5,8% | 5,56% |
| EBITDA 1 | 8.311 | 7.586 | 9.237 | 13.580 | 16.691 | 19.647 | 22.555 | 24.743 |
| Variatie | - | -8,72% | 21,76% | 47,02% | 22,91% | 17,71% | 14,8% | 9,7% |
| Bedrijfsresultaat (EBIT) 1 | 7.340 | 9.928 | 13.350 | 14.534 | 16.928 | 18.538 | 20.755 | 22.887 |
| Variatie | - | 35,26% | 34,47% | 8,87% | 16,47% | 9,51% | 11,96% | 10,27% |
| Betaalde rente 1 | -782 | -862 | -1.251 | -1.282 | -1.284 | -1.120 | -953,2 | -940,7 |
| Resultaat voor belastingen (EBT) 1 | 3.916 | -265 | 2.501 | 6.899 | 8.691 | 12.702 | 15.295 | 17.211 |
| Variatie | - | -106,77% | 1.043,77% | 175,85% | 25,97% | 46,15% | 20,42% | 12,52% |
| Nettowinst (verlies) 1 | 3.196 | 112 | 3.288 | 5.961 | 7.035 | 9.919 | 11.947 | 13.392 |
| Variatie | - | -96,5% | 2.835,71% | 81,3% | 18,02% | 41% | 20,44% | 12,1% |
| Datum van publicatie | 11-02-21 | 10-02-22 | 09-02-23 | 08-02-24 | 06-02-25 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Balansprognose: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | 11.867 | 24.383 | 22.923 | 22.510 | 24.570 | 20.263 | 12.878 | 3.070 |
| Variatie | - | 105,47% | -5,99% | -1,8% | 9,15% | -17,53% | -36,45% | -76,16% |
| Datum van publicatie | 11-02-21 | 10-02-22 | 09-02-23 | 08-02-24 | 06-02-25 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Verwachte kasstroom: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 961 | 1.091 | 1.091 | 1.361 | 1.924 | 2.472 | 2.462 | 2.423 |
| Variatie | - | 13,53% | 0% | 24,75% | 41,37% | 28,46% | -0,39% | -1,58% |
| Vrije kasstroom (FCF) 1 | 3.838 | 4.872 | 8.717 | 8.984 | 9.937 | 7.603 | 12.703 | 14.335 |
| Variatie | - | 26,94% | 78,92% | 3,06% | 10,61% | -23,48% | 67,07% | 12,85% |
| Datum van publicatie | 11-02-21 | 10-02-22 | 09-02-23 | 08-02-24 | 06-02-25 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 31,22% | 20,27% | 20,83% | 29,64% | 30,87% | 33,97% | 36,86% | 38,31% |
| EBIT-marge (%) | 27,58% | 26,53% | 30,1% | 31,73% | 31,31% | 32,06% | 33,92% | 35,44% |
| EBT-marge (%) | 14,71% | -0,71% | 5,64% | 15,06% | 16,07% | 21,96% | 25% | 26,65% |
| Nettomarge (%) | 12,01% | 0,3% | 7,41% | 13,01% | 13,01% | 17,15% | 19,53% | 20,74% |
| FCF-marge (%) | 14,42% | 13,02% | 19,65% | 19,61% | 18,38% | 13,15% | 20,76% | 22,2% |
| Vrije kasstroom/nettoresultaat (%) | 120,09% | 4.350% | 265,12% | 150,71% | 141,25% | 76,65% | 106,33% | 107,04% |
Winstgevendheid | ||||||||
| ROA | 4,99% | 8,77% | 3,26% | 11,48% | 12,51% | 10,81% | 11,85% | 12,68% |
| ROE | 36,72% | 27,51% | 27,23% | 29,77% | 32,11% | 31,78% | 32% | 31,59% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | 1,43x | 3,21x | 2,48x | 1,66x | 1,47x | 1,03x | 0,57x | 0,12x |
| Schuld/vrije kasstroom | 3,09x | 5x | 2,63x | 2,51x | 2,47x | 2,67x | 1,01x | 0,21x |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 3,61% | 2,92% | 2,46% | 2,97% | 3,56% | 4,27% | 4,02% | 3,75% |
| CAPEX / EBITDA (%) | 11,56% | 14,38% | 11,81% | 10,02% | 11,53% | 12,58% | 10,92% | 9,79% |
| CAPEX / FCF (%) | 25,04% | 22,39% | 12,52% | 15,15% | 19,36% | 32,51% | 19,38% | 16,9% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 3,655 | 4,179 | 6,287 | 6,623 | 7,589 | 10,43 | 11,52 | 13,16 |
| Variatie | - | 14,33% | 50,46% | 5,34% | 14,58% | 37,48% | 10,39% | 14,27% |
| Dividend per aandeel 1 | 2,8 | 2,87 | 2,9 | 2,9 | 3,1 | 3,213 | 3,376 | 3,535 |
| Variatie | - | 2,5% | 1,05% | 0% | 6,9% | 3,64% | 5,07% | 4,72% |
| Nettoactief per aandeel 1 | 11,91 | 27,69 | 23,93 | 25,06 | 26,09 | 28,89 | 33,14 | 38,54 |
| Variatie | - | 132,51% | -13,6% | 4,74% | 4,13% | 10,72% | 14,72% | 16,28% |
| WPA 1 | 2,44 | 0,08 | 2,11 | 3,81 | 4,5 | 6,384 | 7,694 | 8,775 |
| Variatie | - | -96,72% | 2.537,5% | 80,57% | 18,11% | 41,86% | 20,52% | 14,05% |
| Aantal aandelen (in duizend) | 1.312.660 | 1.549.159 | 1.549.528 | 1.549.926 | 1.550.317 | 1.550.658 | 1.550.658 | 1.550.658 |
| Datum van publicatie | 11-02-21 | 10-02-22 | 09-02-23 | 08-02-24 | 06-02-25 | - | - | - |
1USD
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | 21,9x | 18,2x |
| PBR-ratio | 4,84x | 4,22x |
| EV/omzet | 4,1x | 3,76x |
| Dividendrendement | 2,3% | 2,41% |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
20
Laatste slotkoers
139,98USD
Gemiddelde koersdoel
179,12USD
Spread / Gemiddelde doel
+27,96%
Kwartaalomzet - Afwijkingspercentage
Kies jouw editie
Alle financiële informatie op nationaal niveau
